Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 39,522 $ 22,474
Accounts receivable 27 17
Prepaid expenses, deposits, and other current assets 2,172 1,865
Total current assets 41,721 24,356
Fixed assets, net 1,502 1,592
Operating lease right-of-use assets 1,884 2,008
Intangible assets, net 2,940 3,445
Other assets 1,078 1,108
Total assets 49,125 32,509
Current liabilities:    
Accounts payable 625 1,056
Accrued expenses and other current liabilities 2,190 1,447
Operating lease liabilities, current portion 1,051 962
Senior Secured Convertible Note - at fair value 11,900
Due To: PAVmed Inc. - MSA Fee and operating expenses 7,627 4,960
Total current liabilities 23,393 8,425
Operating lease liabilities, less current portion 826 1,037
Total liabilities 24,219 9,462
Commitments and contingencies
Stockholders’ Equity:    
Preferred stock, $0.001 par value, 20,000,000 shares authorized; Series A Convertible Preferred Stock, issued and outstanding 13,625 at March 31, 2023 and no shares issued and outstanding at December 31, 2022 13,625
Common stock, $0.001 par value, 100,000,000 shares authorized; 41,753,603 and 40,518,792 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 42 41
Additional paid-in capital 125,561 121,081
Accumulated deficit (114,322) (98,075)
Total Stockholders’ Equity 24,906 23,047
Total Liabilities and Stockholders’ Equity $ 49,125 $ 32,509